Bellicum Pharmaceuticals

Lanx

Lanx is a privately held global spine company that develops and markets a full line of fusion technologies with a focus on minimally invasive and biologics products. Acquired by BioMet in 2013.

Select Venture Capital & Financial Partners

Chicago Growth Partners Goldman Sachs